
On 28 July, Nigeria joined the global community in marking World Hepatitis Day, an annual event dedicated to raising awareness about one of the most persistent public health challenges of our time. The theme for this year, “Hepatitis – Let’s Break It Down,” highlighted the urgency of dismantling barriers to prevention, diagnosis, and treatment. Across the world, country-specific activities were held, ranging from free screenings to treatment programmes. In Nigeria, however, the day was marked by mixed feelings among stakeholders, who questioned the nation’s preparedness to confront the scale of the hepatitis crisis.
According to the World Health Organisation, Nigeria carries the third highest hepatitis burden worldwide, with more than 20 million chronic hepatitis B and C infections. Data from the Federal Ministry of Health and Social Welfare reveal that 18.2 million Nigerians live with hepatitis B, while 2.5 million live with hepatitis C. These figures highlight the enormity of the challenge and the need for urgent, coordinated action.
In 2025, the Federal Ministry of Health and Social Welfare launched Project 365, a nationwide hepatitis elimination campaign aimed at achieving eradication by 2030. While the initiative is commendable, structural gaps remain. Chief among these is inadequate investment in the health sector. Despite the Abuja Declaration of 2001, which required African countries to allocate 15 per cent of their national budgets to health, Nigeria has yet to meet this target. The shortfall in funding has made it increasingly difficult to contain infectious diseases such as hepatitis, tuberculosis, and HIV.
Ahead of this year’s World Hepatitis Day, WHO Regional Director for Africa, Mohamed Janabi, noted that viral hepatitis remains a major public health challenge across the continent. Although new hepatitis B infections declined by 25 per cent between 2015 and 2024, the disease continues to devastate populations. His remarks emphasised the need to address structural weaknesses that hinder elimination efforts.
Similarly, Dr Teresa Kasaeva, Director of the WHO Department for HIV, TB, Hepatitis and STIs, stressed the importance of stronger political commitment and greater investment. She urged governments to accelerate the implementation of proven policies and interventions, reminding stakeholders that effective vaccines, reliable diagnostics, curative treatments for hepatitis C, and lifelong therapy for hepatitis B already exist. The challenge lies not in the absence of tools but in the lack of political will and resources to deploy them effectively.
Kasaeva outlined five areas requiring urgent attention. The first is turning evidence into action by using existing tools to change the course of hepatitis. The second is putting people and communities at the centre of the response by engaging those with lived experience and civil society organisations in policy and service delivery. The third is closing the gap in access to services, ensuring prevention, testing, and treatment reach all populations regardless of location or resources. The fourth is integrating hepatitis services into primary healthcare and universal health coverage frameworks. The fifth is investing in innovation to develop new solutions that complement existing tools and sustain progress.
As Africa’s most populous nation, Nigeria has a responsibility to set the pace for others. The Federal Ministry of Health and Social Welfare must prioritise making diagnosis, early treatment, and prevention services accessible to all citizens. Collaboration with international donor agencies will be crucial in mobilising funds for the procurement of vaccines, diagnostics, and medicines. By strengthening partnerships and scaling up interventions, Nigeria can demonstrate leadership in the continental fight against hepatitis.
Ultimately, the elimination of hepatitis in Nigeria depends on political will. Increased budgetary allocation to health, in line with the Abuja Declaration, would provide the resources needed to expand services and sustain elimination efforts. More importantly, it would signal the government’s determination to protect the health of its citizens. Without such commitment, the goal of eliminating hepatitis by 2030 will remain elusive.
World Hepatitis Day 2026 has once again highlighted the scale of Nigeria’s hepatitis burden and the urgent need for decisive action. While initiatives such as Project 365 are laudable, they must be backed by adequate funding, strong political will, and meaningful community engagement. Nigeria has the tools to break down hepatitis, but success will depend on whether the government and stakeholders can muster the resolve to act. That is where breaking down hepatitis truly begins.





